Riboflavin-Responsive Glutaryl CoA Dehydrogenase Deficiency

    December 2005 in “ Molecular Genetics and Metabolism ”
    R. A. Chalmers, Murray D. Bain, Johannes Zschocke
    Studysummary This study reports that riboflavin may increase enzymatic activity in a GCDH-deficient patient with specific mutations, but doesn't fully normalize urinary organic acid levels.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on doi.org →
    Discuss this study in the Community →